Marsh, Chubb collaborate on COVID-19 vaccine program
COVAX is designed to expedite the development and manufacture of COVID-19 vaccines and to ensure their fair and equitable distribution in all countries of the world. The Chubb-Marsh collaboration will provide up to $ 150 million in insurance to the COVAX No-Fault Compensation program to cover compensation for eligible individuals in the 92 lower-income countries and economies collectively known as Gavi COVAX Advance Market Commitment (Gavi COVAX Advance Market Commitment). AMC) eligible economies. Insurance broker Marsh directed the worldwide placement of the cover. Chubb is the main insurer, backed by 10 other insurers in the US, UK, Germany, Ireland, Switzerland and Bermuda. The delivery of COVID-19 vaccines in 2021 will be the largest and fastest proliferation of novel vaccines in the world in history. COVAX aims to deliver up to two billion doses by the end of the year, including up to 1.7 billion doses to the 92 AMC-eligible countries and economies. "Chubb is excited t...